Details on the third patient have not been released, but Mr. Musk said in an interview streamed on X that all three humans with Neuralink implants are doing well.
Neuralink was implanted in the first human brain about a year ago. Mr. Musk said since then, the company has upgraded the device with more electrodes, higher bandwidth and longer battery life. The company plans to implant the device in 20 to 30 more people this year.
In November, Elon Musk got approval to conduct Neuralink’s first international clinical study.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.